Analyst Recommendations

Citigroup analyst issues NEUTRAL recommendation for ATKR on February 4, 2026 11:34AM ET. The previous analyst recommendation was Neutral.ATKR was trading at $69.89 at issue of the analyst...

February 4, 2026   ATKR 0.20%

UBS analyst issues BUY recommendation for DVA on February 4, 2026 11:34AM ET. The previous analyst recommendation was Buy.DVA was trading at $134.73 at issue of the analyst...

February 4, 2026   DVA -1.64%

Citigroup analyst issues BUY recommendation for EMR on February 4, 2026 11:35AM ET. The previous analyst recommendation was Buy.EMR was trading at $152.1 at issue of the analyst...

February 4, 2026   EMR 0.79%

Citigroup analyst issues NEUTRAL recommendation for ITW on February 4, 2026 11:36AM ET. The previous analyst recommendation was Neutral.ITW was trading at $278.91 at issue of the analyst...

February 4, 2026   ITW 0.78%

Wells Fargo analyst issues UNDERWEIGHT recommendation for ITW on February 4, 2026 11:37AM ET. The previous analyst recommendation was Underweight.ITW was trading at $278.91 at issue of the...

February 4, 2026   ITW 0.78%

Jefferies analyst issues HOLD recommendation for EPD on February 4, 2026 11:37AM ET. The previous analyst recommendation was Hold.EPD was trading at $34.63 at issue of the analyst...

February 4, 2026   EPD 1.00%

Citigroup analyst issues BUY recommendation for TER on February 4, 2026 11:37AM ET. The previous analyst recommendation was Buy.TER was trading at $282.98 at issue of the analyst...

February 4, 2026   TER 3.82%

Citigroup analyst issues BUY recommendation for PEP on February 4, 2026 11:39AM ET. The previous analyst recommendation was Buy.PEP was trading at $162.85 at issue of the analyst...

February 4, 2026   PEP -1.35%

Citigroup analyst issues NEUTRAL recommendation for CLX on February 4, 2026 11:39AM ET. The previous analyst recommendation was Neutral.CLX was trading at $114.98 at issue of the analyst...

February 4, 2026   CLX 1.41%

Wells Fargo analyst issues OVERWEIGHT recommendation for MDLZ on February 4, 2026 11:38AM ET. The previous analyst recommendation was Overweight.MDLZ was trading at $59.47 at issue of the...

February 4, 2026   MDLZ 4.14%